Cytotaxonomy of Trypanosoma cruzi (Chagas, 1909): Differentiation of T. cruzi I (TcI) and T. cruzi II (TcII) Genotypes Using Cytogenetic Markers | Zendy

Ana Beatriz Bortolozo de Oliveira | Zendy; A. R. Ribeiro | Zendy; Fernanda Fernandez Madeira | Zendy; Natália Regina Cesaretto | Zendy; João Aristeu da Rosa | Zendy; Maria Tercília Vilela de AzeredoOliveira | Zendy; Kaio Cesar Chaboli Alevi | Zendy

Open Access

Cytotaxonomy of Trypanosoma cruzi (Chagas, 1909): Differentiation of T. cruzi I (TcI) and T. cruzi II (TcII) Genotypes Using Cytogenetic Markers

Author(s) -

Ana Beatriz Bortolozo de Oliveira,

A. R. Ribeiro,

Fernanda Fernandez Madeira,

Natália Regina Cesaretto,

João Aristeu da Rosa,

Maria Tercília Vilela de AzeredoOliveira,

Kaio Cesar Chaboli Alevi

Publication year - 2019

Publication title -

american journal of tropical medicine and hygiene

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.015

H-Index - 151

eISSN - 1476-1645

pISSN - 0002-9637

DOI - 10.4269/ajtmh.18-0650

Subject(s) - trypanosoma cruzi , chagas disease , biology , genotype , orcein , genetics , virology , gene , staining , parasite hosting , world wide web , computer science

Chagas disease is a public health problem caused by the Trypanosoma cruzi , and the T. cruzi I (TcI) and T. cruzi II (TcII) groups are considered important genotypes from the clinical point of view. Currently, the groups need to be molecularly analyzed for their identification; thus, we cytogenetically analyzed these groups with the objective of developing more accessible techniques for the characterization of these parasites. TcI and TcII groups were differentiated by nucleus characterization with lacto-acetic orcein (TcI-nucleus with positive heteropycnosis and TcII-nucleus with negative heteropycnosis), emphasizing the importance of the application of this technique for epidemiological and clinical studies of Chagas disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research